Empirical Wealth Management
RPRX icon

Empirical Wealth Management’s Royalty Pharma RPRX Stock Holding History

Empirical Wealth Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$225K Sell
3,852
-773
-17% -$45.6K ﹤0.01% 1056
2026
Q2 		$259K Buy
+4,625
New +$241K ﹤0.01% 916
2026
Q1 		– Sell
-6,424
Closed -$248K – 1033
2025
Q4 		$248K Sell
6,424
-456
-7% -$17.4K ﹤0.01% 772
2025
Q3 		$243K Buy
+6,880
New +$249K ﹤0.01% 692

Other funds holding RPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Empirical Wealth Management's RPRX Position: Q3 2026 in Review

Empirical Wealth Management reduced its Royalty Pharma (RPRX) stake by 17% in Q3 2026, selling an estimated $45.6K and leaving 3,852 shares worth $225K. The position accounts for ﹤0.01% of the portfolio, ranked #1056.

Empirical Wealth Management first reported a position in RPRX in Q3 2025 and has held it in 4 quarters since. The position peaked at $259K in Q2 2026. 393 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Empirical Wealth Management held 3,852 shares of Royalty Pharma worth $225K as of Q3 2026.
  • Empirical Wealth Management sold 773 Royalty Pharma shares in Q3 2026, an estimated $45.6K.
  • Royalty Pharma made up ﹤0.01% of Empirical Wealth Management's portfolio in Q3 2026, its #1056 holding.
  • Empirical Wealth Management first reported a position in Royalty Pharma in Q3 2025 and has held it in 4 quarters since.
  • Empirical Wealth Management's Royalty Pharma position peaked at $259K in Q2 2026.
  • 393 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Empirical Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.